• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴发性肝衰竭患者的纤连蛋白替代治疗

Fibronectin replacement in patients with fulminant hepatic failure.

作者信息

Hughes R D, Imawari M, Bihari D, Almasio P L, Langley P G, Williams R

出版信息

Eur J Clin Invest. 1986 Oct;16(5):352-6. doi: 10.1111/j.1365-2362.1986.tb01008.x.

DOI:10.1111/j.1365-2362.1986.tb01008.x
PMID:3100301
Abstract

Patients with fulminant hepatic failure have low levels of the plasma opsonizing protein fibronectin together with cardiovascular disturbances similar to those in septic shock where microembolization of capillary beds by particulate debris has been proposed to lead to multi-organ failure. Six patients with fulminant hepatic failure received a bolus injection of a concentrated fibronectin-rich preparation. The mean plasma immunoreactive fibronectin level increased from 53 +/- SE 12 micrograms ml-1 initially to 295 +/- 30 micrograms ml-1 (P less than 0.001) at 1 h after fibronectin administration. The in vitro plasma opsonic activity was also increased from 5.6 +/- 3.6% of control to 102 +/- 13% (P less than 0.005) at 1 h. No similar effect was observed with the clearance of microaggregated albumin, but as its clearance is probably not dependent on fibronectin it may reflect a different aspect of reticuloendothelial cell function. No significant changes were observed in cardiopulmonary function or oxygen utilization and it is possible this is because clearance of opsonized particles is limited by damage to Kupffer cells.

摘要

暴发性肝衰竭患者血浆调理素蛋白纤连蛋白水平较低,同时伴有与感染性休克相似的心血管紊乱,在感染性休克中,有人提出毛细血管床被颗粒性碎片微栓塞会导致多器官衰竭。6例暴发性肝衰竭患者接受了富含纤连蛋白的浓缩制剂大剂量注射。纤连蛋白给药后1小时,血浆免疫反应性纤连蛋白平均水平从最初的53±标准误12微克/毫升升至295±30微克/毫升(P<0.001)。体外血浆调理活性在1小时时也从对照的5.6±3.6%升至102±13%(P<0.005)。微聚集白蛋白清除率未观察到类似效应,但由于其清除率可能不依赖于纤连蛋白,这可能反映了网状内皮细胞功能的不同方面。心肺功能和氧利用未观察到显著变化,这可能是因为调理颗粒的清除受库普弗细胞损伤的限制。

相似文献

1
Fibronectin replacement in patients with fulminant hepatic failure.暴发性肝衰竭患者的纤连蛋白替代治疗
Eur J Clin Invest. 1986 Oct;16(5):352-6. doi: 10.1111/j.1365-2362.1986.tb01008.x.
2
Fibronectin and Kupffer cell function in fulminant hepatic failure.纤维连接蛋白与暴发性肝衰竭中库普弗细胞的功能
Dig Dis Sci. 1985 Nov;30(11):1028-33. doi: 10.1007/BF01315599.
3
Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.通过输注纯化的人血浆纤连蛋白逆转手术、创伤和烧伤患者的调理素缺乏。与实验观察结果的相关性。
Am J Med. 1986 Feb;80(2):229-40. doi: 10.1016/0002-9343(86)90014-8.
4
Characterization of the molecular forms of fibronectin in fulminant hepatic failure.暴发性肝衰竭中纤连蛋白分子形式的特征分析
Hepatology. 1986 Nov-Dec;6(6):1340-5. doi: 10.1002/hep.1840060620.
5
Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.暴发性肝炎患者血浆纤维连接蛋白的前瞻性研究:与感染及死亡率的关系
J Hepatol. 1995 Jul;23(1):8-13. doi: 10.1016/0168-8278(95)80304-1.
6
Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.血浆纤连蛋白(调理素糖蛋白):其由血管内皮细胞合成及其在创伤后心肺完整性方面与网状内皮系统功能相关的作用。
Am J Med. 1980 Apr;68(4):577-94. doi: 10.1016/0002-9343(80)90310-1.
7
Fibronectin in acute and subacute hepatic failure.急性和亚急性肝衰竭中的纤连蛋白
J Clin Gastroenterol. 1989 Jun;11(3):314-9. doi: 10.1097/00004836-198906000-00014.
8
Fibronectin in fulminant hepatic failure.暴发性肝衰竭中的纤连蛋白
Br Med J (Clin Res Ed). 1982 Oct 30;285(6350):1231-2. doi: 10.1136/bmj.285.6350.1231.
9
Reversal of fibronectin and opsonic deficiency in patients. A controlled study.患者中纤连蛋白和调理素缺乏的逆转。一项对照研究。
Ann Surg. 1984 Jan;199(1):87-96. doi: 10.1097/00000658-198401000-00015.
10
Fibronectin and liver disease.纤连蛋白与肝脏疾病
Hepatology. 1987 Jul-Aug;7(4):800-1.